about
Evolution of JAK-STAT pathway components: mechanisms and role in immune system developmentThe potential link between gut microbiota and IgE-mediated food allergy in early lifeZebrafish as a model for leukemia and other hematopoietic disordersThe Src-like tyrosine kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF) and docks to the activated G-CSF receptorDirect binding of Shc, Grb2, SHP-2 and p40 to the murine granulocyte colony-stimulating factor receptorBiosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanaseSpecificity and affinity motifs for Grb2 SH2-ligand interactionsEvolution of Class I cytokine receptorsFrom transcriptome to biological function: environmental stress in an ectothermic vertebrate, the coral reef fish Pomacentrus moluccensisG-CSF does not influence C2C12 myogenesis despite receptor expression in healthy and dystrophic skeletal muscle.Signaling mechanisms of cytokine receptors and their perturbances in disease.A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects.The multiple mini-interview: how long is long enough?Harnessing zebrafish for the study of white blood cell development and its perturbation.EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer ModelNovel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.Versican processing by a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats proteinases-5 and -15 facilitates myoblast fusion.Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.Characterisation of the urease-encoding gene complex of Yersinia enterocolitica.Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.Genetic and molecular diagnosis of severe congenital neutropenia.Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancerGranulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more.Shooting the messenger: targeting signal transduction pathways in leukemia and related disorders.The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity.Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.Zebrafish as a genetic model in pre-clinical drug testing and screening.Chicken interferons, their receptors and interferon-stimulated genes.Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications.Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy.Pegasus, the 'atypical' Ikaros family member, influences left-right asymmetry and regulates pitx2 expression.Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice.Conserved IL-2Rγc Signaling Mediates Lymphopoiesis in Zebrafish.Evolution of Cytokine Receptor Signaling.G-CSF treatment can attenuate dexamethasone-induced reduction in C2C12 myotube protein synthesis.Characterisation of chicken ZAP.Characterization of zebrafish polymerase III promoters for the expression of short-hairpin RNA interference molecules.Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.Systematic investigation of oxygen and growth factors in clinically valid ex vivo expansion of cord blood CD34(+) hematopoietic progenitor cells.
P50
Q21134741-B574A249-9A63-486E-9CA8-6CFC05E3D2DDQ26822564-1C85AC11-657A-485A-A6F8-865B1EF6CAF1Q28081638-F3B445AD-75FD-45AF-B38B-93E5D33463FFQ28286905-B99D88AA-4AC9-42FB-B177-0C0EDC0833F2Q28289488-6846BDD1-9A8C-4C36-A835-DAB111CD2DDEQ28594757-AF318180-CA94-42F6-8278-6151EE52FBABQ31088288-88D04700-0BF7-48E6-8F89-EC66BD57A807Q33291265-E98567D4-74F5-4CA0-BB14-01F7F0DAC005Q33301598-FC539345-F9D0-4996-92BC-75B1CBCA8E40Q33579922-9E5FEC2C-F70D-42EF-B599-B48A9559BBB6Q33861766-93982284-1566-4A60-A101-14BA3BCE8570Q34501320-6BE311CE-0C03-49C5-9494-94B2B251A362Q34927485-AA3DE9E5-B63F-44E9-A93A-13C39EC49006Q35877659-D09717DD-45DA-4E2F-8B94-6BB4577E42CCQ36352817-D6905038-CEAF-489E-931A-4F851FDEE77FQ36375198-E0D3A466-2C24-48D9-8EF3-9F5A2B90A6C6Q36543792-C52D2CCE-8479-4537-819C-66F9C439D616Q36701486-9C276D0E-C777-40C7-BDFC-CE1F22DA9D13Q36735597-1E9CCB37-625D-40F7-9D6F-BBE1911868FDQ36900749-FA2A35C9-DFE2-434D-9E05-8213D9266508Q37080992-1F81774B-3050-45E1-9E37-A43719590B95Q37287780-A74B8051-3511-4C0D-B997-50A462686B56Q37459590-0D4F3501-D5B9-4D93-8805-ADCEA3F6E2D8Q37584680-A17E5A2B-A2C6-4D5F-80CF-DFC8F4EF6520Q37767013-321B9D4B-B655-46E3-B4D3-E2207531ED76Q37863312-B58CBCF3-8302-478D-85AA-6EE198049D89Q37910273-D7C12663-3D95-4901-802B-581E5EBB4602Q38092194-31A94013-5182-4995-8F80-670D55BFBEDCQ38113334-D5F955A3-13CA-4BED-BF11-951EE378A7E8Q38175651-6B288CA7-A77B-4023-B7CE-B4AE7D93B957Q38211431-FF02A839-1FF9-49BA-9EDE-74293FECF111Q38317040-A22CEEE3-994D-4917-821A-048CA1254DF0Q38349895-2BFAD09D-A524-4ED9-9A3B-7D00C29ABAF7Q38817949-7D50844E-88F5-405F-96CA-DE6C62C86C92Q38869059-4E21C30F-3E5C-4D77-B856-471ABB16580AQ38908727-9F3C2485-685B-4423-BFF1-7E2C31CEF943Q38990120-07494D4D-F101-4771-A11A-C477088BD024Q39266839-0B516AFE-0EC1-4592-BA8A-E7F0D320B0B0Q39535066-E9C67444-2170-41D7-93D6-4B785EDA4B84Q39639930-8DD23067-229C-4C79-9568-7D7D740AFE0C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alister C Ward
@nl
Alister C Ward
@sl
Alister C. Ward
@en
Alister C. Ward
@es
type
label
Alister C Ward
@nl
Alister C Ward
@sl
Alister C. Ward
@en
Alister C. Ward
@es
prefLabel
Alister C Ward
@nl
Alister C Ward
@sl
Alister C. Ward
@en
Alister C. Ward
@es
P106
P1153
7402090618
P21
P31
P496
0000-0001-7945-7975